Product Code: ETC13043982 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Ovarian Cancer Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Ovarian Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Ovarian Cancer Drugs Market - Industry Life Cycle |
3.4 India Ovarian Cancer Drugs Market - Porter's Five Forces |
3.5 India Ovarian Cancer Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Ovarian Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Ovarian Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Ovarian Cancer Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Ovarian Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of ovarian cancer in India |
4.2.2 Rising awareness about ovarian cancer screening and early detection |
4.2.3 Technological advancements in drug development for ovarian cancer |
4.3 Market Restraints |
4.3.1 High cost of ovarian cancer drugs |
4.3.2 Lack of reimbursement policies for expensive cancer treatments in India |
4.3.3 Stringent regulatory requirements for drug approval in the country |
5 India Ovarian Cancer Drugs Market Trends |
6 India Ovarian Cancer Drugs Market, By Types |
6.1 India Ovarian Cancer Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Ovarian Cancer Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Ovarian Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.4 India Ovarian Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 India Ovarian Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.1.6 India Ovarian Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Ovarian Cancer Drugs Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Ovarian Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.3 India Ovarian Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021 - 2031F |
6.2.4 India Ovarian Cancer Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2.5 India Ovarian Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Ovarian Cancer Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Ovarian Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 India Ovarian Cancer Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 India Ovarian Cancer Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.5 India Ovarian Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 India Ovarian Cancer Drugs Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Ovarian Cancer Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Ovarian Cancer Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 India Ovarian Cancer Drugs Market Revenues & Volume, By Cancer Centers, 2021 - 2031F |
6.4.5 India Ovarian Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
7 India Ovarian Cancer Drugs Market Import-Export Trade Statistics |
7.1 India Ovarian Cancer Drugs Market Export to Major Countries |
7.2 India Ovarian Cancer Drugs Market Imports from Major Countries |
8 India Ovarian Cancer Drugs Market Key Performance Indicators |
8.1 Number of new cases diagnosed annually |
8.2 Adoption rate of innovative treatment options |
8.3 Patient survival rates post-treatment |
8.4 Research and development investment in ovarian cancer drugs |
8.5 Number of clinical trials conducted in India for ovarian cancer treatments |
9 India Ovarian Cancer Drugs Market - Opportunity Assessment |
9.1 India Ovarian Cancer Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Ovarian Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Ovarian Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Ovarian Cancer Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Ovarian Cancer Drugs Market - Competitive Landscape |
10.1 India Ovarian Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Ovarian Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |